Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2000
07/27/2000CA2627837A1 Pharmaceutical compositions for alleviating discomfort
07/27/2000CA2361272A1 33 human secreted proteins
07/27/2000CA2360065A1 Lipoprotein complexes and compositions containing them
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359145A1 Exocytosis pathway proteins and methods of use
07/27/2000CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359105A1 New morpholinobenzamide salts
07/27/2000CA2359096A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2356349A1 Novel angiogenesis inhibitors
07/27/2000CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/26/2000EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use
07/26/2000EP1022272A1 Substituted fused heterocyclic compounds
07/26/2000EP1022023A1 Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
07/26/2000EP1022022A1 Composition for inhibiting increase of blood sugar level or lowering blood sugar level
07/26/2000EP1022018A1 Use of at least one extract of at least one non-photosynthetic filamentous bacterium as slimming agent
07/26/2000EP1021549A2 SENSE mRNA THERAPY
07/26/2000EP1021456A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
07/26/2000EP1021442A1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
07/26/2000EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/26/2000EP1021401A1 Calcitriol derivatives and their uses
07/26/2000EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
07/26/2000EP1021194A1 New improved formulation for treatment of osteoporosis
07/26/2000EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS
07/26/2000EP1021191A2 Tightening and/or reducing the size of body parts containing fat cells
07/26/2000EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha
07/26/2000EP1021185A1 Didhydropyrimidines and uses thereof
07/26/2000EP1021175A1 Compounds and methods for therapeutic intervention in preventing diabetic complications
07/26/2000EP1021167A1 High and low load formulations of igf-i in multivesicular liposomes
07/26/2000EP0762890B1 Treatment of diabetes
07/26/2000CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
07/26/2000CN1261286A CD154 blockade therapy for pancreatin islet tissue transplantation
07/26/2000CN1261281A Peptide parathyroid hormone analogs
07/26/2000CN1261279A Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
07/26/2000CN1261277A Novel substituted imidazole compounds
07/26/2000CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them.
07/26/2000CN1261273A Delayed-release dosage forms of sertraline
07/26/2000CN1054857C Motilin-like polypeptides with gastrointinal motor stimulating activity
07/26/2000CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical
07/26/2000CN1054855C Non-reducing oligosaccharide and its production and use
07/26/2000CN1054846C Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties
07/25/2000US6093822 5-arylindole derivatives
07/25/2000US6093812 Process for the stereospecific synthesis of azetidinones
07/25/2000US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/25/2000US6093729 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
07/25/2000US6093715 Process for producing riboflavin-containing granules
07/25/2000US6093697 Derivatives of small amino disaccharides of given formula; for treatment of disorders of glucose metabolism
07/25/2000US6093561 Human lysophospholipase
07/25/2000US6093423 Reduced absorption of fatty acids
07/25/2000CA2167688C Methods and compositions for inhibiting uridine secretion
07/25/2000CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
07/25/2000CA1341060C Use of amylin agonists in the treatment of diabetes mellitus
07/20/2000WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000WO2000042201A2 Human peptidases
07/20/2000WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
07/20/2000WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042030A1 Hypolipidemic and antioxidant morpholine derivatives
07/20/2000WO2000042029A1 1-heterocycle substituted diarylamines
07/20/2000WO2000042027A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000042024A1 Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt
07/20/2000WO2000042023A1 Substituted imidazoles, their preparation and use
07/20/2000WO2000042022A1 Benzoheterocycles and their use as mek inhibitors
07/20/2000WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors
07/20/2000WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
07/20/2000WO2000042001A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
07/20/2000WO2000041708A1 Composition for treating obesity and aesthetic treatment method
07/20/2000WO2000041701A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones for treating insulin dependent and non-insulin dependent diabetes
07/20/2000WO2000041699A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones
07/20/2000WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof
07/20/2000WO2000041528A2 Improved controlled release compositions and method
07/20/2000WO2000041505A2 Anthranilic acid derivatives
07/20/2000WO2000041504A2 Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
07/20/2000WO2000041484A2 Novel use of phospholipids of vegetable and animal origin in nutritional therapy
07/20/2000WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor
07/20/2000WO2000001687A9 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/20/2000WO1999000373A8 Benzimidazole derivatives
07/20/2000WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
07/20/2000CA2360464A1 Human peptidases
07/20/2000CA2359986A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000CA2359980A1 Derivatives of monosaccharides as cell adhesion inhibitors
07/20/2000CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000CA2356706A1 Novel exendin agonist formulations and methods of administration thereof
07/20/2000CA2355374A1 1-heterocycle substituted diarylamines
07/20/2000CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors
07/20/2000CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
07/20/2000CA2349180A1 Anthranilic acid derivatives
07/20/2000CA2323711A1 Composition for treating obesity and aesthetic treatment method
1 ... 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 ... 1298